Effect of aspirin on cancer incidence and mortality in older adults.

Effect of aspirin on cancer incidence and mortality in older adults.

BACKGROUND: ASPirin in Reducing Events in the Elderly (ASPREE), a randomized double-blind placebo-controlled trial (RCT) of daily low-dose aspirin (100 mg) in older adults, showed an increase in all-cause mortality, primarily due to cancer. In contrast prior RCTs, mainly involving younger individual...

Full description

Bibliographic Details
Main Authors: McNeil, John J, Gibbs, Peter, Orchard, Suzanne G, Lockery, Jessica E, Bernstein, Wendy B, Cao, Yin, Ford, Leslie, Haydon, Andrew, Kirpach, Brenda, Macrae, Finlay, McLean, Catriona, Millar, Jeremy, Murray, Anne M, Nelson, Mark R, Polekhina, Galina, Reid, Christopher, Richmond, Ellen, Rodríguez, Luz Maria, Shah, Raj C, Tie, Jeanne, Umar, Asad, van Londen, G.J., Ronaldson, Kathlyn, Wolfe, Rory, Woods, Robyn L, Zalcberg, John, Chan, Andrew T, ASPREE Investigator Group
Format: Journal Article
Language:English
Published: 2020
Subjects:
ASPREE Investigator Group
Online Access:http://purl.org/au-research/grants/nhmrc/334047
http://hdl.handle.net/20.500.11937/80802

Internet

http://purl.org/au-research/grants/nhmrc/334047
http://hdl.handle.net/20.500.11937/80802

Similar Items